BRNS

Barinthus Biotherapeutics plc

3.56 USD
+0.91 (+34.34%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Barinthus Biotherapeutics plc stock is up 22.76% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 February’s closed higher than January.

About Barinthus Biotherapeutics plc

Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in developing novel T cell immunotherapeutics to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company was formerly known as Vaccitech plc and changed its name to Barinthus Biotherapeutics plc in November 2023. Barinthus Biotherapeutics plc was founded in 2016 and is headquartered in Harwell, the United Kingdom.